Regeneron Says FDA Halts Pain Killer Drug Development

by Kathy Jones on  December 28, 2010 at 9:07 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

In a major blow for Regeneron Pharmaceuticals, the US Food and Drug Administration (FDA) has put an end to the development of its new pain killer drug after a similar study by another company resulted in a serious nerve problem in a volunteer.
 Regeneron Says FDA Halts Pain Killer Drug Development
Regeneron Says FDA Halts Pain Killer Drug Development

The experimental drug, REGN475/SAR164877, is being developed by Regeneron along with Sanofi-Aventis SA but was asked to halt the research after a similar study by Pfizer which led to the development of avascular necrosis in the patient.

Pfizer is currently developing a similar NGF-inhibitor but a number of patients who took part in the study had to undergo joint replacement surgeries due avascular necrosis.

The FDA then contacted both the companies, requesting it to suspend their trials until a clear picture emerged.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Thoracic Outlet Syndrome Top 15 Natural Painkillers 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...